Related links
DALLAS, TEXAS -
Leah Siegel was diagnosed 18 months ago with stage 4 breast cancer. She was diagnosed the same day her youngest son was born. She said she's on her second round of chemotherapy.
"I was in a trial last spring and I was on it through the summer and it maintained my cancer but it didn't put it into remission so I was off that trial and now i'm trying to get into another one," Said Leah.
Leah and others will be interested in the I-Spy-2 clinical trial which was announced today in Washington, D.C. The trial will use genetic or biological markers from individual patients to screen promising new treatments to see which ones work best.
It's called personalized medicine. UT Southwestern Medical Center professor of surgery David Euhus said the fast track drug trail is needed.
"They are stacked up waiting to be tested and they obviously can't be tested in the traditional way, it would take lifetimes to get through the backlog of potentially valuable drugs right now." Said Dr. Euhus.
Doctors will use genetic tests to match patients with drugs. There are many types of breast cancers and leah wants to be a part of the study.
"They have told me that my cancer is treatable but not curable, so again, another reason why the drugs are very important because all they can do is treat my cancer, there is no hope to really cure it," Said Leah.
Amazingly there is hope. Dr. Euhus said that last year a stage 4 breast cancer patient took a test drug and is now cancer free.
"She had cancer all over her body, had failed chemotherapy, just took this oral pill and all the cancer went away," Said Dr. Euhus.
That is the hope for Leah her husband and three young kids. She said she hopes there is a genetic wonder drug out there with her name on it.
"This sounds really encouraging for people like myself who time isn't really on my side," Said Leah.
The study will last five years and cost 26 million dollars. UT Southwestern expects to start accepting patients sometime this summer. As man as twelve drugs will be tested.
"I was in a trial last spring and I was on it through the summer and it maintained my cancer but it didn't put it into remission so I was off that trial and now i'm trying to get into another one," Said Leah.
Leah and others will be interested in the I-Spy-2 clinical trial which was announced today in Washington, D.C. The trial will use genetic or biological markers from individual patients to screen promising new treatments to see which ones work best.
It's called personalized medicine. UT Southwestern Medical Center professor of surgery David Euhus said the fast track drug trail is needed.
"They are stacked up waiting to be tested and they obviously can't be tested in the traditional way, it would take lifetimes to get through the backlog of potentially valuable drugs right now." Said Dr. Euhus.
Doctors will use genetic tests to match patients with drugs. There are many types of breast cancers and leah wants to be a part of the study.
"They have told me that my cancer is treatable but not curable, so again, another reason why the drugs are very important because all they can do is treat my cancer, there is no hope to really cure it," Said Leah.
Amazingly there is hope. Dr. Euhus said that last year a stage 4 breast cancer patient took a test drug and is now cancer free.
"She had cancer all over her body, had failed chemotherapy, just took this oral pill and all the cancer went away," Said Dr. Euhus.
That is the hope for Leah her husband and three young kids. She said she hopes there is a genetic wonder drug out there with her name on it.
"This sounds really encouraging for people like myself who time isn't really on my side," Said Leah.
The study will last five years and cost 26 million dollars. UT Southwestern expects to start accepting patients sometime this summer. As man as twelve drugs will be tested.
Digg
Twitter
Facebook
StumbleUpon
